Regeneron Pharmaceuticals Inc
F:RGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Regeneron Pharmaceuticals Inc
F:RGO
|
US |
|
Ferrovial SE
NASDAQ:FER
|
NL |
|
A
|
Anheuser-Busch Inbev SA
XMUN:1NBA
|
BE |
|
Harmony Gold Mining Company Ltd
OTC:HGMCF
|
ZA |
|
H
|
Halliburton Co
XHAM:HAL
|
US |
|
B
|
BAE Systems PLC
XMUN:BSP
|
UK |
|
B
|
Barratt Developments P L C
XBER:3BA
|
UK |
|
Alimentation Couche-Tard Inc
TSX:ATD
|
CA |
|
F
|
FibroGen Inc
F:1FG
|
US |
|
A
|
AT & S Austria Technologie & Systemtechnik AG
XMUN:AUS
|
AT |
|
G
|
goeasy Ltd
F:1ES
|
CA |
|
Intershop Holding AG
SIX:ISN
|
CH |
|
B
|
Bank Handlowy w Warszawie SA
SWB:6HW
|
PL |
|
Delta Electronics Thailand PCL
SET:DELTA
|
TH |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BOY
|
ES |
|
S
|
SPAR Group Ltd
XBER:S8A
|
ZA |
|
C
|
Community Health Systems Inc
XMUN:CG5
|
US |
|
Hanjaya Mandala Sampoerna Tbk PT
F:HSZ
|
ID |
|
Schibsted ASA
F:XPGB
|
NO |
|
R
|
Rentokil Initial PLC
DUS:RTO1
|
UK |
|
Q
|
Qiagen NV
XHAM:QIA
|
NL |
|
Konami Group Corp
F:KOA0
|
JP |
|
H
|
Hong Kong and China Gas Co Ltd
XHAM:HCG
|
HK |
Wall St Price Targets
RGO Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RGO is 746.29 EUR with a low forecast of 571.24 EUR and a high forecast of 954.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RGO's stock price target?
Price Target
746.29
EUR
According to Wall Street analysts, the average 1-year price target for RGO is 746.29 EUR with a low forecast of 571.24 EUR and a high forecast of 954.25 EUR.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 19%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 8 years is 11%.
What is the Pre-Tax Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 22%. The projected CAGR for the next 3 years is 15%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 8 years is 8%.
